Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Intratumoural Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Centre, Prospective Safety and Feasibility Study

NCT05880472 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05880472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05880472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Intratumoural Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Centre, Prospective Safety and Feasibility Study
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 1, 2023
Completion date
April 22, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer